These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
100 related items for PubMed ID: 2596957
21. Fusion between enveloped viruses and erythrocyte membranes is induced by the isoprenoid alkane pristane (2,6,10,14-tetramethylpentadecane). Janz S, Shacter E, Herrmann A. Cancer Biochem Biophys; 1994 Apr; 14(1):1-14. PubMed ID: 7796384 [Abstract] [Full Text] [Related]
22. Spontaneous development of plasmacytomas in a selected subline of BALB/cJ mice. Silva S, Wang Y, Babonits M, Imreh S, Wiener F, Klein G. Eur J Cancer; 1997 Mar; 33(3):479-85. PubMed ID: 9155535 [Abstract] [Full Text] [Related]
29. Effect of subcutaneously administered 2,6,10,14-tetramethylpentadecane on plasmacytoma growth. Platica M, Bojko C, Steiner G, Hollander VP. Cancer Res; 1980 Jul; 40(7):2229-33. PubMed ID: 6248200 [Abstract] [Full Text] [Related]
30. Chromosomal translocations activating myc sequences and transduction of v-abl are critical events in the rapid induction of plasmacytomas by pristane and abelson virus. Ohno S, Migita S, Wiener F, Babonits M, Klein G, Mushinski JF, Potter M. J Exp Med; 1984 Jun 01; 159(6):1762-77. PubMed ID: 6202819 [Abstract] [Full Text] [Related]
31. Indomethacin inhibition of pristane plasmacytomagenesis in genetically susceptible inbred mice. Potter M. Adv Exp Med Biol; 1999 Jun 01; 469():151-6. PubMed ID: 10667324 [No Abstract] [Full Text] [Related]
32. Genetics of susceptibility to plasmacytoma induction. I. BALB/cAnN (C), C57BL/6N (B6), C57BL/Ka (BK), (C times B6)F1, (C times BK)F1, and C times B recombinant-inbred strains. Potter M, Pumphrey JG, Bailey DW. J Natl Cancer Inst; 1975 Jun 01; 54(6):1413-7. PubMed ID: 1133851 [Abstract] [Full Text] [Related]
33. Increased susceptibility of old mice to plasmacytoma induction. Sato K, Bloom ET, Hirokawa K, Makinodan T. J Gerontol; 1986 Jan 01; 41(1):24-9. PubMed ID: 3484487 [Abstract] [Full Text] [Related]
34. Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane. Satoh M, Hamilton KJ, Ajmani AK, Dong X, Wang J, Kanwar YS, Reeves WH. J Immunol; 1996 Oct 01; 157(7):3200-6. PubMed ID: 8816434 [Abstract] [Full Text] [Related]
35. Susceptibility and resistance to J3V1 retrovirus-induced murine plasmacytomagenesis in reconstituted severe combined immunodeficient mice. Hilbert DM, Pumphrey JG, Troppmair J, Rapp UR, Rudikoff S. Oncogene; 1993 Jul 01; 8(7):1993-2000. PubMed ID: 7685514 [Abstract] [Full Text] [Related]
36. Transplantation of primary plasma cell tumor without 2,6,10,14- tetramethylpentadecane (pristane) treatment of the hosts. Platica M, Bojko C, Hollander VP. Cancer Res; 1980 Mar 01; 40(3):579-81. PubMed ID: 7471077 [Abstract] [Full Text] [Related]
37. Indomethacin is a potent inhibitor of pristane and plastic disc induced plasmacytomagenesis in a hypersusceptible BALB/c congenic strain. Potter M, Wax J, Jones GM. Blood; 1997 Jul 01; 90(1):260-9. PubMed ID: 9207461 [Abstract] [Full Text] [Related]
38. Association of elevated mutagenesis in the spleen with genetic susceptibility to induced plasmacytoma development in mice. Felix K, Kelliher K, Bornkamm GW, Janz S. Cancer Res; 1998 Apr 15; 58(8):1616-9. PubMed ID: 9563470 [Abstract] [Full Text] [Related]
39. Plasmacytomas of the NZB mouse. Morse HC, Riblet R, Asofsky R, Weigert M. J Immunol; 1978 Nov 15; 121(5):1969-72. PubMed ID: 712074 [Abstract] [Full Text] [Related]